Related Experiment Videos
Molecular definition of tumor antigens recognized by T lymphocytes
P van der Bruggen1, B Van den Eynde
1Ludwig Institute for Cancer research, Brussels, Belgium.
Abstract:
Several tumor antigens recognized by T cells have now been identified at the molecular level. Various mechanisms can account for their expression: activation of normally silent genes; point mutations; chromosome translocations; and post-translational modifications of proteins. This led to the notion that potential tumor-rejection antigens can be shared by a significant proportion of human tumors. This may have important implications in cancer immunotherapy, especially since tumors expressing a defined antigen can be identified on the basis of the expression of the relevant gene.
Insights
Scientists identified molecular targets called tumor antigens, which are crucial for cancer immunotherapy. These antigens, arising from various genetic mechanisms, can be shared across many tumors, offering new therapeutic strategies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- T cell-recognized tumor antigens have been identified at the molecular level.
- Tumor antigen expression can result from various mechanisms, including gene activation, mutations, translocations, and post-translational modifications.
- The identification of specific tumor antigens is key to understanding tumor immunology.
Purpose of the Study:
- To explore the molecular basis of tumor antigen expression.
- To investigate the potential for shared tumor antigens across different human tumors.
- To highlight the implications for cancer immunotherapy.
Main Methods:
- Molecular identification of tumor antigens.
- Analysis of gene expression and protein modification mechanisms.
- Comparative analysis of antigen expression across tumor types.
Main Results:
- Several tumor antigens recognized by T cells have been characterized.
- Diverse mechanisms contribute to tumor antigen expression.
- The concept of shared tumor antigens across a significant proportion of human tumors has emerged.
Conclusions:
- Shared tumor antigens present a promising avenue for cancer immunotherapy.
- The ability to identify tumors expressing specific antigens facilitates targeted therapeutic approaches.
- Molecular characterization of tumor antigens is critical for advancing cancer treatment.